Taiwan · Delayed Price · Currency is TWD Taho Pharmaceuticals Statistics
Total Valuation
TPEX:6467 has a market cap or net worth of TWD 6.86 billion. The enterprise value is 6.47 billion.
| Market Cap | 6.86B |
| Enterprise Value | 6.47B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6467 has 51.39 million shares outstanding. The number of shares has increased by 17.56% in one year.
| Current Share Class | 51.39M |
| Shares Outstanding | 51.39M |
| Shares Change (YoY) | +17.56% |
| Shares Change (QoQ) | +8.44% |
| Owned by Insiders (%) | 17.72% |
| Owned by Institutions (%) | 9.15% |
| Float | 38.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 881.94 |
| PB Ratio | 15.39 |
| P/TBV Ratio | 15.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -39.00 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -37.64 |
Financial Position
The company has a current ratio of 35.75, with a Debt / Equity ratio of 0.03.
| Current Ratio | 35.75 |
| Quick Ratio | 35.53 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.08 |
| Interest Coverage | -273.51 |
Financial Efficiency
Return on equity (ROE) is -48.14% and return on invested capital (ROIC) is -29.66%.
| Return on Equity (ROE) | -48.14% |
| Return on Assets (ROA) | -29.12% |
| Return on Invested Capital (ROIC) | -29.66% |
| Return on Capital Employed (ROCE) | -37.74% |
| Revenue Per Employee | 288,111 |
| Profits Per Employee | -6.15M |
| Employee Count | 27 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -59.80 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 68.54 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 86.99 |
| Average Volume (20 Days) | 1,256,676 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6467 had revenue of TWD 7.78 million and -165.97 million in losses. Loss per share was -3.37.
| Revenue | 7.78M |
| Gross Profit | 4.88M |
| Operating Income | -171.49M |
| Pretax Income | -165.97M |
| Net Income | -165.97M |
| EBITDA | -168.68M |
| EBIT | -171.49M |
| Loss Per Share | -3.37 |
Balance Sheet
The company has 401.52 million in cash and 14.01 million in debt, giving a net cash position of 387.51 million or 7.54 per share.
| Cash & Cash Equivalents | 401.52M |
| Total Debt | 14.01M |
| Net Cash | 387.51M |
| Net Cash Per Share | 7.54 |
| Equity (Book Value) | 445.78M |
| Book Value Per Share | 8.68 |
| Working Capital | 393.42M |
Cash Flow
In the last 12 months, operating cash flow was -162.46 million and capital expenditures -9.51 million, giving a free cash flow of -171.97 million.
| Operating Cash Flow | -162.46M |
| Capital Expenditures | -9.51M |
| Free Cash Flow | -171.97M |
| FCF Per Share | -3.35 |
Margins
| Gross Margin | 62.67% |
| Operating Margin | -2,204.54% |
| Pretax Margin | -2,133.50% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6467 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.56% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.42% |
| FCF Yield | -2.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |